BioMedNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Proprietary Medical Device Passes Registration Tests, Slated to Start Clinical Trial
Jan 4, 2022
AnPac Bio-Medical Science (NASDAQ: ANPC), a U.S.- and China-based biotechnology company focused on early cancer screening and detection, announced that its Class III medical device for lung cancer auxiliary diagnosis has passed stringent and rigorous registration tests; the tests were conducted at a testing laboratory selected by China’s regulatory agent for medical products, the National Medical Products Administration (“NMPA”). The device passed tests designed to measure accuracy, precision, stability, linearity, accuracy and repeatability in sample addition, cross-contamination, electromagnetic compatibility (“EMC”), and reliability and performance under various environmental conditions. According to AnPac Bio, completion of the tests is an important achievement in the process of obtaining a Class III medical device registration certificate. The company noted that one major step remains before obtaining final approval of a registration certificate — clinical trials testing the device are scheduled to begin at two qualified medical institutions in Q1 2022. “We are very excited about this significant milestone and major accomplishment,” said AnPac Bio CEO and chair Dr. Chris Yu in the press release. “By passing this challenging and rigorous medical device registration test, we have demonstrated our technical and commercialization capabilities. Lung cancer is a major cancer and there are very few approved registration certificates for lung cancer, so obtaining a Class III medical device registration certificate for lung cancer auxiliary diagnosis would enhance our competitive position in the marketplace and position us for increased revenues. This is one of AnPac Bio’s most important projects, along with our plan to commercialize and market our CDA test as a laboratory developed test in the United States. We now expect significant further progress in obtaining Class III medical device registration certificate in China and LDT in the US in 2022.”
To view the full press release, visit https://ibn.fm/0kyWK
About AnPac Bio-Medical Science Co. Ltd.
AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 150 issued patents as of Sept. 30, 2021. With two certified clinical laboratories in China and one CLIA- and CAP-accredited clinical laboratory in the United States, AnPac Bio performs a suite of cancer screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. According to Frost & Sullivan, AnPac Bio ranked third worldwide among companies offering next-generation, early-cancer screening and detection technologies in terms of the number of clinical samples for cancer screening and detection in 2019. The company has a significant cancer screening and detection, based on approximately 43,980 clinical samples as of Sept. 30, 2021. AnPac Bio’s CDA technology platform has been shown in retrospective validation studies to detect the risk of more than 20 different cancer types with high sensitivity and specificity. For more information about the company, visit www.AnPacBio.com.
NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
More women are taking testosterone to treat menopause symptoms. Does science support that?
Testosterone is touted as a cure-all for menopause symptoms on social media, and more women are now taking it off-label. Scientists want more research.
What Canada's wastewater reveals about drug use in 8 cities
New StatCan data shows sharply different drug-use patterns across eight Canadian cities, with methamphetamine elevated in parts of the Prairies and Moncton, cocaine comparatively high in Halifax and fentanyl highest in Metro Vancouver.
Whistleblower alleges millions of Driscoll’s berries sent to Canada with excess chemical levels
A whistleblower lawsuit in California is alleging millions of pounds of Driscoll's fruit containing non-compliant levels of pesticides and chemicals crossed the border into Canada, and the company tried to cover it up.
This medical device heading to space with Joshua Kutryk is also helping people here on Earth
On Oct. 1 Canadian Space Agency astronaut Joshua Kutyrk will blast off from Cape Canaveral, Fla., and he’s bringing some innovative Canadian tech with him.
The EU Just Asked Canada If We Could Be Best Buddies...Legally, And Canadians Are Responding In The Most Hilarious Way
Give me a baguette, a ciggy, and an espresso any day. View Entire Post ›
Travel leaders gather in the Maldives for World Travel Awards
The Maldives is preparing to welcome travel and tourism leaders from across the region for the World Travel Awards Asia, Oceania & Indian Ocean Gala Ceremony 2026, powered by Bank of Maldives. The ceremony will take place at CROSSROADS Maldives on Sunday, 27 September 2026, coinciding with World Tourism Day. The evening will bring together leading travel, tourism and hospitality brands from across Asia, Oceania and the Indian Ocean to celebrate excellence across a wide range of categories, including hotels, resorts, airlines, tour operators, destinations and tourism attractions.
Fari Islands Festival 2026 brings together creativity, culture, wellness and conservation
The Maldives’ Fari Islands archipelago came alive from 13–15 August as the second edition of the Fari Islands Festival unfolded across Patina Maldives and The Ritz-Carlton Maldives. Guided by its ‘One Festival, Every Sense’ philosophy, the festival welcomed an international community of artists, cultural voices, chefs, musicians, wellness practitioners and conservationists, including headline contributor Rosamund Pike and acclaimed designer Sean Wotherspoon.
Travel Tech Leaders Agree: Artificial Intelligence Will Transform Tourism
On September 27th, UN Tourism celebrates World Tourism Day. In 2026, it will centre on how digitalization and Artificial Intelligence are redesigning tourism. To mark the date, Belvera Partners, a PR firm exclusively focused on supporting B2B travel technology companies, has brought together thought leaders across the travel technology ecosystem to explore the opportunities, challenges, and responsibilities associated with the rapid adoption of technology, in general, and AI, in particular, across hospitality, distribution, and travel experiences.
Brazil sees 14.03% increase in European tourists in 2026; British arrivals reach highest volume in 1
European visitors to Brazil is experiencing its best January-to-August period in two decades. In the first eight months of 2026, the country recorded 1.28 million tourist arrivals from Europe, a 14.03% increase compared to the same period in 2025.
China commits to ‘global gateway’ WTM London with largest-ever pavilion and extensive line-up
The China Pavilion at this year’s WTM London will be almost 22% bigger than last year, with the stand configured to combine live cultural experiences, destination discovery and high-value business networking across all the three days of the world’s most influential travel and tourism event, powered by RX Global. The expanded footprint reflects the importance China places on rebuilding international tourism links through WTM London, while deepening cooperation with the UK and wider global travel trade.
Endless Trails: Discover Lithuania’s Wild Side on Foot
Beyond Lithuania’s cities lies a landscape of quiet drama: ancient forests, misty bogs, glacial lakes and dunes shaped by the Baltic winds. Best explored on foot, these wild places offer a different side of Europe — one where you can walk for hours through seemingly untouched landscapes and still be back in town by evening. The Baltic nation is attracting growing international interest with an impressive 74% of visitors. Beyond its historic cities, cultural attractions and increasingly acclaimed food scene, Lithuania offers another compelling reason to visit: an extraordinary variety of accessible natural landscapes and its dynamic seasonality.
Cincy Region On The Rise: British Airways Expands Daily Service For Summer 2027
The Cincy Region is set for an even stronger connection with the UK in 2027, as British Airways announces a significant expansion of its nonstop service between London Heathrow and Cincinnati/Northern Kentucky International Airport (CVG).
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.